Search company, investor...

Hexaell Biotech

Founded Year



Series C | Alive

Total Raised


About Hexaell Biotech

Hexaell Biotech is a biopharmaceutical company focused on severe liver disease and cell therapy using cell differentiation and production technology. The company was founded in 2015 and is based in Shanghai, China.

Headquarters Location

Building D No. 55 Huiyuan Road

Shanghai, Shanghai,


+86 021-59967620

Missing: Hexaell Biotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Hexaell Biotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Hexaell Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Hexaell Biotech is included in 2 Expert Collections, including Biopharma Tech.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Hexaell Biotech Frequently Asked Questions (FAQ)

  • When was Hexaell Biotech founded?

    Hexaell Biotech was founded in 2015.

  • Where is Hexaell Biotech's headquarters?

    Hexaell Biotech's headquarters is located at Building D, Shanghai.

  • What is Hexaell Biotech's latest funding round?

    Hexaell Biotech's latest funding round is Series C.

  • How much did Hexaell Biotech raise?

    Hexaell Biotech raised a total of $7.25M.

  • Who are the investors of Hexaell Biotech?

    Investors of Hexaell Biotech include Lapam Capital, Wu Capital, ZJSTIC, Hengxu Capital, Sherpa Venture Capital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.